Colitis-Associated Cancer

  • Masato Kusunoki

Table of contents

  1. Front Matter
    Pages i-viii
  2. Masato Kusunoki
    Pages 1-19
  3. Clinical Features

    1. Front Matter
      Pages 21-21
    2. Koji Tanaka, Toshimitsu Araki, Yuji Toiyama, Yoshiki Okita, Yasuhiko Mohri, Masato Kusunoki
      Pages 23-39
    3. Motoi Uchino, Hiroki Ikeuchi, Toshihiro Bando, Kei Hirose, Nobuyuki Hida, Shiro Nakamura
      Pages 41-57
  4. Diagnosis

    1. Front Matter
      Pages 59-59
    2. Yoshiki Okita, Toshimitsu Araki, Koji Tanaka, Yuji Toiyama, Keiichi Uchida, Masato Kusunoki
      Pages 61-83
    3. Yuji Toiyama, Toshimitsu Araki, Koji Tanaka, Yasuhiko Mohri, Masato Kusunoki
      Pages 85-105
  5. Surgical Treatment

    1. Front Matter
      Pages 107-107
    2. Toshimitsu Araki, Yuji Toiyama, Yoshiki Okita, Koji Tanaka, Yasuhiro Inoue, Keiichi Uchida et al.
      Pages 109-130
    3. Hiroki Ikeuchi, Motoi Uchino, Toshihiro Bando, Kei Hirose, Nobuyuki Hida, Shiro Nakamura
      Pages 131-150

About this book


As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn’s disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn’s disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.


Biomarker Colitic Cancer Crohn's Disease Ulcerative Colitis prophylactic abdominoperineal resection

Editors and affiliations

  • Masato Kusunoki
    • 1
  1. 1.Department of Gastrointestinal and Pediatric SurgeryMie University Graduate School of MedicineTsuJapan

Bibliographic information